Jose A. Lasalde-Dominicci U.S. Patent No: Pending Caballero Rivera D, Biaggi-Labiosa NM, Avilez-Pagan E, Lasalde-Dominicci JA U.S. Patent No: 10,676,518 Valance-Washington A, Ferrer-Acosta Y, Morales J, Reyes-Baez F U.S. Patent No: 10,597,462 Lasalde-Dominicci; Jose A., Quesada-Gonzalez; Orestes, Rodriguez-Cordero, Josue, Baez-Pagan; Carlos U. S. Patent No: 10, 358, 475 Lasalde-Dominicci; José A., Quesada-González; Orestes, Rodríguez-Cordero, Josué, Báez-Pagan; Carlos U.S. Patent No: 10,155,221 Rivera JM, Negrón LM U.S. Patent No: 10,106,572 Rosenthal JJC, Montiel-González MF U.S. Patent No: 9,650,627PATENTS
USPTO
Pat NumTitle Inventors Date
1 10,155,221 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
physiological resting
membrane potential across
a lipid matrix of variable
composition.Lasalde-Dominicci;
Jose A., QuesadaGonzalez; Orestes,
Rodriguez-Cordero;
Josue, Baez-Pagan;
CarlosDecember
2018
2 10,106,572 Supramolecular hacky
sacks (SHS), method of
synthesis and applications
thereofRivera; Jose M,
Negron; Luis MOctober
2018
3 9,650,627 Site-directed RNA editing Rosenthal; Joshua J. C.,
Montiel-Gonzalez; Maria
FernandaMay 2017
4 10,676,518 A4B2 nicotinic
acetylcholine receptors
with reduced or increased
nicotine sensitivity and
transgenic mouse model
for the same.Caballero-Rivera; Daniel,
Biaggi-Labiosa; Nilza M,
Aviles-Pagan; Emir,
Lasalde-Dominicci; José
A.June 2020
5 10,358,475 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
physiological resting
membrane potential across
a lipid matrix of variable
compositionJose A. LasaldeDominicci, Orestes
Quesada-Gonzalez, Josue
Rodriguez-Cordero,
Carlos Baez-PaganJuly 2019
6 10,597,462 Anti-TLT-1 antibody and
uses thereofWashigton Anthony V March 2020
7 11,440,001 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
September 2022
8 physiological resting
membrane potential across
a lipid matrix of variable
composition
PUBLICATIONS
Publications up to January 2025 ” View pdf ” ⇒
Yuan C, Velázquez-Marrero C, Bernardo A, Treistman SN Morales-Cruz M, Figueroa CM, González-Robles T, Delgado Y, Molina A, Méndez J, Morales M, Griebenow K Pézier A, Jezzini SH, Marie B, Blagburn JM Delgado Y, Morales-Cruz M, Hernández-Román J, Martínez Y, Griebenow K Vallejo D, Habib MR, Delgado N, Vaasjo LO, Croll RP, Miller MW Mosquera L, Colón JM, Santiago JM, Torrado AI, Meléndez M, Segarra AC, Rodríguez-Orengo JF, Miranda JD Rivera-Oliver M, Díaz-Ríos M Hernández JS, Barreto-Torres G, Kuznetsov AV, Khuchua Z, Javadov S Velázquez-Marrero C, Ortiz-Miranda S, Marrero HG, Custer EE, Treistman SN, Lemos JR Méndez J, Morales Cruz M, Delgado Y, Figueroa CM, Orellano EA, Morales M, Monteagudo A, Griebenow K Vega-Meléndez GS, Blagburn JM, Blanco RE Cabán-Hernández K, Espino AM Acevedo JM, Díaz-Ríos M Habiba K, Makarov VI, Avalos J, Guinel MJF, Weiner BR, Morell G Pézier A, Blagburn JM
PloS One. 2014; 9 (9): e107917. DOI: 10.1371/journal.pone.0107917
J. Nanobiotechnology. 2014; 12 33. DOI: 10.1186/s12951-014-0033-9
J. Neurosci. Off. J. Soc. Neurosci. 2014; 34 (35): 11691–11704. DOI: 10.1523/JNEUROSCI.1939-14.2014
BMC Biochem. 2014; 15 16. DOI: 10.1186/1471-2091-15-16
J. Comp. Neurol. 2014; 522 (11): 2532–2552. DOI: 10.1002/cne.23548
Brain Res. 2014; 1561 11–22. DOI: 10.1016/j.brainres.2014.03.002
Life Sci. 2014; 101 (1–2): 1–9. DOI: 10.1016/j.lfs.2014.01.083
J. Cell. Mol. Med. 2014; 18 (4): 709–720. DOI: 10.1111/jcmm.12220
J. Neurosci. Off. J. Soc. Neurosci. 2014; 34 (10): 3733–3742. DOI: 10.1523/JNEUROSCI.2505-13.2014
Mol. Pharm. 2014; 11 (1): 102–111. DOI: 10.1021/mp400400j
J. Neurosci. Res. 2014; 92 (1): 13–23. DOI: 10.1002/jnr.23303
Acta Trop. 2013; 128 (3): 591–597. DOI: 10.1016/j.actatropica.2013.08.012
J. Comp. Physiol. A Neuroethol. Sens. Neural. Behav. Physiol. 2013; 199 (12): 1105–1116. DOI: 10.1007/s00359-013-0853-3
Carbon. 2013; 64 341–350. DOI: 10.1016/j.carbon.2013.07.084
PloS One. 2013; 8 (8): e71419. DOI: 10.1371